Last update July 15, 2015
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Deflazacort is also known as
Deflazacort in other languages or writings:
Deflazacort belongs to this group or family:
Main tradenames from several countries containing Deflazacort in its composition:
|Tmax||1.5 - 2||hours|
|T½||1 - 2||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Drug which is oxazolinic-derived from Prednisolone with similar properties to the latter.
At latest update no published data on excretion into breast milk were found.
Due to a moderate high molecular weight and rapid elimination time it is probably safe while breastfeeding, mostly in non long-term treatments.
Until more data on this drug is available, it would be preferred other options that are known to be safer, specially during the neonatal period and prematurity.